
Acknowledging professional writing support in publications – are we doing enough?
It is standard practice to name professional medical writers in publications, but how should we acknowledge subcontracted or freelance support?
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
It is standard practice to name professional medical writers in publications, but how should we acknowledge subcontracted or freelance support?
Sandra Petty discusses the Null Hypothesis Initiative and looks to the future of reporting negative data.
Professor Marcus Munafò discusses the importance of reproducibility in scientific research and how we can overcome barriers to achieving it.
Missed the meeting? Read our report to get up to speed!
Find out why PLOS wants institutions to pay an annual open access fee under the Community Action Publishing model, rather than charging researchers per article.
Get up to speed with the recently published PRISMA 2020 statement, which contains updated guidelines for reporting systematic reviews.
Missed the meeting? Read our report on the symposium entitled “Research integrity & the medical communicator: what we do when no one is watching.”
Missed the meeting? Read our report on the symposium entitled “Research integrity & the medical communicator: what we do when no one is watching.”
David Mellor from the Center for Open Science explains how the company is supporting and facilitating the open science movement.
Researchers identify flaws in current COVID-19 research and publication processes, and provide solutions using Open Science principles
Get up to date with the key improvements in research recognition, including information on contributor roles taxonomy (CRediT) and updates to ORCID.
Medical Publishing Insights and Practices (MPIP) initiative members share perspectives on the benefits of publishing industry-sponsored research open access.
A recent BMJ editorial discusses the benefits and risks of the use of preprints during the current coronavirus pandemic.
Slávka Baróniková shares her opinions on open access publishing and suggests how this can be successfully achieved within pharma.
The increasing range of publication choices and demand for open access are explored in this sponsored article from Taylor & Francis Group.
Systematic reviews are generally considered gold standard evidence in healthcare, but a founding member of Cochrane believes steps can be taken to increase transparency and reduce bias in their protocols.